Targeting Mitochondria 2018 Confirmed Speakers

Among the Targeting Mitochondria 2018 Speakers
Vladimir Gogvadze

Mitochondrial involvement in cell life/death regulation: Presentation of new scientific results

Vladimir Gogvadze, Korolinska Institute, Stockholm, Sweden
IDpicture IK hl The transcriptomic and proteomic landscape of mitochondrial dysfunction in mouse

Inge Kühl, CNRS - Institut de Biologie Intégrative de la cellule (I2BC), France
Luca Scorrano

Mitochondrial dynamics in cell life and death

Luca Scorrano, University of Padova, Padova, Italy
H Westerblad Mechanism and therapeutic potential of cyclophilin inhibitors for prevention of mitochondrial myopathy progression

Håkan Westerblad, Karolinska Intitutet, Sweden
Culmsee Metabolic switches saving mitochondria from oxidative stress
Carsten Culmsee, Universität Marburg, Marburg, Germany
Faltus-Timo The legal framework for mitochondrial therapy
Identifying and preventing legal pitfalls within the translation from bench to bedside
Timo Faltus, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany
Matthew Young

Utilizing a human hepatoma cell line to study off-target effects of drugs on mitochondrial DNA maintenance and bioenergetics

Matthew Young, Southern Illinois University School of Medicine, Carbondale, USA
Currais Targeting mitochondrial metabolism, geroprotection to treating Alzheimer’s disease
Antonio Currais, The Salk Institute for Biological Studies, La Jolla, USA
Werner Koopman Cellomics of mitochondrial morphofunction
Werner Koopman, RadboudUMC University, Nijmegen, The Netherlands
maik huttemann Therapeutic application of specific near-infrared light wavelengths that inhibit cytochrome C oxidase results in robust neuroprotection
Maik Hüttemann, Wayne State University School of Medicine, Detroit, USA
Sang-Bing Ong

Healing the heart through mitochondrial dynamics: a love-hate relationship

Sang-Bing Ong, Duke-NUS Medical School, Singapore
Alessia Angelin Mitochondrial Medicine: Recent Advances & Perspectives
Alessia Angelin, Children's Hospital of Philadelphia, USA
John Vissing

Phase 2 motor study of Omaveloxolone in patients with mitochondrial myopathies

John Vissing, Copenhagen University, Copenhagen, Denmark
Adam Szewczyk Role of mitochondrial potassium channels in cellular function during health and disease
Adam Szewczyk, Nencki Institute of Experimental Biology, Warsaw, Poland
Lobo Mary Kay Role of mitochondrial potassium channels in cellular function during health and disease
Mary Kay Lobo, University of Maryland School of Medicine, Baltimore, USA
   
 

https://targeting-mitochondria.com/images/2018/vrac/preliminary-PROGRAM.jpg